These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7786067)

  • 21. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
    Agarwal AK
    J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S7-S12; quiz S17-21. PubMed ID: 17098634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case management of the anemic patient: epoetin alfa--focus on compliance.
    Currier H
    ANNA J; 1993 Aug; 20(4):470-3. PubMed ID: 8368881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case management of the anemic patient. Epoetin alfa: focus on sexual dysfunction.
    Fearing MO
    ANNA J; 1992 Dec; 19(6):570-1. PubMed ID: 1292419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anemia management protocols: providing consistent hemoglobin outcomes.
    Michael M
    Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case management of the anemic patient. Epoetin alfa: focus on patient teaching.
    Sasak C; Giordano E
    ANNA J; 1990 Apr; 17(2):188-9. PubMed ID: 2327804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case management of the anemic patient. Epoetin alfa: focus on quality of life.
    Butera E
    ANNA J; 1992 Aug; 19(4):410-1. PubMed ID: 1520032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epoetin alfa--focus on the rehabilitation of dialysis patients. Case study of the anemic patient.
    Martin-Lester M
    ANNA J; 1996 Dec; 23(6):630-3. PubMed ID: 9069794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 29. Case management of the anemic patient. Epoetin alfa: focus on inflammation and infection.
    Starmann BL
    ANNA J; 1992 Jun; 19(3):280-1. PubMed ID: 1627012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit.
    To LL; Stoner CP; Stolley SN; Buenviaje JD; Ziegler TW
    Am J Health Syst Pharm; 2001 Nov; 58(21):2061-5. PubMed ID: 11715828
    [No Abstract]   [Full Text] [Related]  

  • 31. Epoetin alfa: a keystone in the treatment of the anemic patient with chronic renal failure. Proceedings of a symposium held April 27, 1989, by the Keystone Chapter of ANNA, Valley Forge, Pennsylvania.
    Binkley L; Gallagher N; Latham D; Nichols E; Prowant B
    ANNA J; 1989 Aug; 16(5):341-51. PubMed ID: 2673076
    [No Abstract]   [Full Text] [Related]  

  • 32. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case management of the anemic patient: epoetin alfa--focus on osteitis fibrosa.
    Morley CT
    ANNA J; 1993 Oct; 20(5):604-7. PubMed ID: 8285805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing an epoetin alfa medication protocol to improve patient care and foster collaboration.
    Shanahan M; Walton S
    ANNA J; 1995 Oct; 22(5):471-6. PubMed ID: 7487190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caring for the renal failure patient: optimizing iron therapy.
    Folkert VW; Javier AM; O'Mara NB
    Nephrol Nurs J; 2002 Dec; 29(6):586-93; quiz 594-5. PubMed ID: 12596608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epoetin alfa--focus on the geriatric patient. Case study of the anemic patient.
    Mathers T
    ANNA J; 1995 Oct; 22(5):494-7. PubMed ID: 7487195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving EPOGEN.
    Johnson CA; Rosowski E; Zimmerman SW
    Adv Perit Dial; 1992; 8():444-7. PubMed ID: 1361844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case management of the anemic patient: epoetin alfa--focus on iron supplementation.
    Kirlin LF
    ANNA J; 1993 Dec; 20(6):678-81. PubMed ID: 8267412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing anemia using laboratory trend analysis. Case study of the anemic patient.
    Aiello J
    ANNA J; 1999 Aug; 26(4):430-3. PubMed ID: 10838975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of subcutaneous low-dose erythropoietin in patients with chronic renal failure despite functional iron deficiency.
    Bedani PL; Cecchetti E; Gilli P
    Nephron; 1995; 71(4):459-60. PubMed ID: 8587628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.